Opportunities and Challenges in China’s Reimbursement Landscape

Published on January 19, 2023

Since National Reimbursement Drug List (NRDL) negotiations were first introduced in 2015 by China’s State Council and National Health and Family Planning Commission (NHFPC), national drug price negotiation for high-cost drugs has become a critical cost containment tool for Chinese payers, and a key opportunity for manufacturers to increase their sales in the Chinese market. In this article, we share our insights regarding new aspects of the drug price negotiations, potential price cut drivers, and implications for manufacturers developing pricing and market access strategies.

Insights from the 2019 NRDL Negotiations

After an initial negotiation pilot in 2016 with five specialty drugs, the NRDL program has seen tremendous growth year by year, resulting in over 126 drugs admitted through the NRDL negotiation pathway. With a total of 150 drugs negotiated, the 2019 NRDL negotiations were the largest round of negotiations to date. In addition, for the…

Continue reading on website
Other news

Triage for a Turnaround: A Medtech Action Plan for COVID-19 Response

January 19, 2023
COVID-19 is more than a health crisis and is infecting the medical technology business at an unprecedented pace. The impact of the pandemic appears to us through a mix of commercial symptoms, such as (1) significant reductions in sales mobility and interaction, (2) rapidly changing purchase demand profiles focused exclusively on procurement of COVID-19 related products, (3) substantial supply chai

Future trading conditions in a post Brexit World?

January 19, 2023
In the run up to the United Kingdom vote on leaving the European Union in 2016, we started assessing the impacts to our clients’ pricing, marketing and sales strategies, researching consumer and business sentiment as we went. Following the vote, the 1,745 days of national debate, uncertainty and political wrangling felt like a lifetime, however we can now finally write our final ‘Brexit’ article.